Product Safety Recalls

Product Recall Tracker

OXACILLIN SODIUM Recall D-0935-2023

Description: Oxacillin for Injection, USP, 1 gram per vial, For IV or IM Use, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India. NDC 25021-146-10.

OXACILLIN SODIUM Recall D-0935-2023 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0935-2023
Event ID92678
BrandOXACILLIN
Generic NameOXACILLIN SODIUM
ManufacturerOXACILLIN SODIUM
Original Package?1
Active SubstanceOXACILLIN SODIUM
Drug RouteINTRAMUSCULAR
DistributionNationwide in the USA
Quantity65,710 vials for 1 g and 2 g strength
Recall ReasonLack of Assurance of Sterility
Drug ClassificationClass II
Drug Code Info20230802
Product NDC25021-146 25021-162
Recall Initiation Date20230711
Report Date20230802
Classification Date20230721
Address1901 N Roselle Rd Ste 450
Schaumburg, IL 60195-3194
United States
Recalling FirmSagent Pharmaceuticals
Initial Notification Letter
Unique Ingredient IdentifierG0V6C994Q5
Drug Application NumberANDA091246
Structured Product Labeling (SPL ID)d20bc39b-1c49-4dd7-8cde-2edcfe061c76
Structured Product Labeling (SPL Set ID)f3bee4d7-82d8-4e2d-8fc8-4446e6fbf999
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.